Home

doboz megszüntet Gyerek palota harangi mariann atorvastatin eeffect of paraoxonase Ázott ünneplés aláírás

Values of paraoxonase activity in high-density lipoproteins isolated... |  Download Scientific Diagram
Values of paraoxonase activity in high-density lipoproteins isolated... | Download Scientific Diagram

Characteristics and laboratory parameters of the study populations a |  Download Table
Characteristics and laboratory parameters of the study populations a | Download Table

Simvastatin Modulates Expression of the PON1 Gene and Increases Serum  Paraoxonase | Arteriosclerosis, Thrombosis, and Vascular Biology
Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase | Arteriosclerosis, Thrombosis, and Vascular Biology

Mariann HARANGI | Professor | MD PhD DSc | University of Debrecen, Debrecen  | Institute of Internal Medicine | Research profile - Page 2
Mariann HARANGI | Professor | MD PhD DSc | University of Debrecen, Debrecen | Institute of Internal Medicine | Research profile - Page 2

Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase  Activities and Concentrations | Arteriosclerosis, Thrombosis, and Vascular  Biology
Promoter Polymorphisms of Human Paraoxonase PON1 Gene and Serum Paraoxonase Activities and Concentrations | Arteriosclerosis, Thrombosis, and Vascular Biology

Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein  Functionality and in Cardiovascular Protection | Antioxidants & Redox  Signaling
Role of Paraoxonase1 in the Regulation of High-Density Lipoprotein Functionality and in Cardiovascular Protection | Antioxidants & Redox Signaling

Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in  arteriosclerosis diseases Litvinov D, Mahini H, Garelnabi M - North Am J  Med Sci
Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases Litvinov D, Mahini H, Garelnabi M - North Am J Med Sci

PDF) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and  renal transplanted patients. A novel cardiovascular biomarker in end-stage  renal disease
PDF) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease

HDL subfraction distribution and HDL function in untreated dyslipidemic  patients
HDL subfraction distribution and HDL function in untreated dyslipidemic patients

Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in  Atherosclerosis | Revista Española de Cardiología
Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in Atherosclerosis | Revista Española de Cardiología

PDF) Effect of atorvastatin therapy on oxidant-antioxidant status and  atherosclerotic plaque formation
PDF) Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation

PDF) Paraoxonase and coronary heart disease | Aldons Lusis - Academia.edu
PDF) Paraoxonase and coronary heart disease | Aldons Lusis - Academia.edu

IJMS | Free Full-Text | Sphingosine 1-Phosphate and Apolipoprotein M Levels  and Their Correlations with Inflammatory Biomarkers in Patients with  Untreated Familial Hypercholesterolemia
IJMS | Free Full-Text | Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia

Paraoxonase-1 arylesterase activity is an independent predictor of  myeloperoxidase levels in overweight patients with or without  cardiovascular complications - ScienceDirect
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications - ScienceDirect

Simvastatin Modulates Expression of the PON1 Gene and Increases Serum  Paraoxonase | Arteriosclerosis, Thrombosis, and Vascular Biology
Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase | Arteriosclerosis, Thrombosis, and Vascular Biology

PDF) Ciprofibrate increases paraoxonase activity in patients with metabolic  syndrome | Illyes Gyorgy - Academia.edu
PDF) Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome | Illyes Gyorgy - Academia.edu

High-density lipoproteins (HDL) is maturated from pre-βmigrating HDL to...  | Download Scientific Diagram
High-density lipoproteins (HDL) is maturated from pre-βmigrating HDL to... | Download Scientific Diagram

Impact of selective LDL apheresis on serum chemerin levels in patients with  hypercholesterolemia – topic of research paper in Clinical medicine.  Download scholarly article PDF and read for free on CyberLeninka open
Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open

Effect of statin therapy on paraoxonase-1 status: A systematic review and  meta-analysis of 25 clinical trials - ScienceDirect
Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials - ScienceDirect

Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in  Atherosclerosis | Revista Española de Cardiología
Concerning the Significance of Paraoxonase-1 and SR-B1 Genes in Atherosclerosis | Revista Española de Cardiología

Plasma lipid and lipoprotein contents in hyperlipidemic patients after... |  Download Scientific Diagram
Plasma lipid and lipoprotein contents in hyperlipidemic patients after... | Download Scientific Diagram

Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in  arteriosclerosis diseases Litvinov D, Mahini H, Garelnabi M - North Am J  Med Sci
Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseases Litvinov D, Mahini H, Garelnabi M - North Am J Med Sci

Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in  overweight patients with newly diagnosed untreated hyper
Paraoxonase-1 and myeloperoxidase correlate with vascular biomarkers in overweight patients with newly diagnosed untreated hyper

HDL subfraction distribution and HDL function in untreated dyslipidemic  patients
HDL subfraction distribution and HDL function in untreated dyslipidemic patients

PDF) Implications of serum paraoxonase activity in obesity, diabetes  mellitus, and dyslipidemia
PDF) Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia